0001181431-13-036345.txt : 20130621
0001181431-13-036345.hdr.sgml : 20130621
20130621175903
ACCESSION NUMBER: 0001181431-13-036345
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130620
FILED AS OF DATE: 20130621
DATE AS OF CHANGE: 20130621
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORONADO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001429260
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205157386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 24 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 24 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weisman Harlan F
CENTRAL INDEX KEY: 0001555563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35366
FILM NUMBER: 13928175
MAIL ADDRESS:
STREET 1: C/O CORONADO BIOSCIENCES, INC.
STREET 2: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rrd384186.xml
FORM 4
X0306
4
2013-06-20
0
0001429260
CORONADO BIOSCIENCES INC
CNDO
0001555563
Weisman Harlan F
C/O CORONADO BIOSCIENCES, INC.
24 NEW ENGLAND EXECUTIVE PARK
BURLINGTON
MA
01803
1
1
0
0
Chairman and CEO
Common Stock
2013-06-20
4
P
0
10000
7.59
A
30000
D
Options to purchase Common Stock
5.72
2022-08-16
Common Stock
25000
25000
D
Options to purchase Common Stock
5.57
2023-01-07
Common Stock
1686590
1686590
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.54 to $7.61, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
One-third of the shares will vest on each of August 16, 2013, 2014 and 2015.
One-third of the shares will vest on each of December 28, 2013, 2014 and 2015, subject to Dr. Weisman's continued employment with the Issuer.
/s/ Dale Ritter, Attorney-in-Fact
2013-06-21